{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:18:43Z","timestamp":1788175123059,"version":"build-2803163510"},"reference-count":19,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Introduction: Hepatitis C virus (HCV) infection prevalence in Italy varies according to geographical areas and clusters of infection. Moreover, epidemiological studies are old, and the actual prevalence of HCV active infections is also affected by the use of direct-acting antiviral therapies (DAAs) that achieve sustained virologic response (SVR) in &gt;95% of treated patients. We aimed to evaluate the prevalence of HCV infections in in- or outpatients referred to a Sicilian hospital. Materials and methods: The study was conducted in the Buccheri La Ferla Hospital, in Palermo (Sicily), from 1 November 2019 to March 2022. We consecutively screened for HCV infections all inpatients who were evaluated on admission to the ward and all outpatients who referred to the central laboratory. All patients were screened using serological detection of HCV antibodies. Results: In the entire cohort, 469 out of 15,550 patients (3%) showed anti-HCV positivity, and this rate progressively increased according to classes of age (0.4% for &lt;40 yrs, 3% for 40\u201360 yrs, 4% for &gt;60\u201380 yrs, and 6.4% for &gt;80 yrs). Among patients with anti-HCV positivity, 44.3% were HCV-RNA negative, 39.2% had HCV-RNA not available, and 16.4% were HCV-RNA positive. In total, 44.1% of patients with HCV-RNA positivity underwent DAA-based antiviral therapy. Conclusions: HCV screening programs can be useful in identifying infected patients at risk of liver disease progression and\/or infection spreading. The implementation of laboratory strategies based on HCV reflex testing, the activation of dedicated linkage-to-care plans, and a focus on higher-risk groups could increase the effectiveness of screening programs.<\/jats:p>","DOI":"10.3390\/v17091252","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:31:41Z","timestamp":1758033101000},"page":"1252","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HCV Screening in a Sicilian Centre: A Descriptive Cohort Profile"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8938-7349","authenticated-orcid":false,"given":"Maria G.","family":"Minissale","sequence":"first","affiliation":[{"name":"Internal Medicine Unit, Buccheri La Ferla Fatebenefratelli Hospital, Via Messina Marine 197, 90123 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Petta","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Promise, Universit\u00e0 di Palermo, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Cartabellotta","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, Buccheri La Ferla Fatebenefratelli Hospital, Via Messina Marine 197, 90123 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Polaris Observatory HCV Collaborators Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study","volume":"2","author":"Blach","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cgh.2011.03.004","article-title":"A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C","volume":"9","author":"Backus","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.gastro.2018.04.008","article-title":"Rete Sicilia Selezione Terapia\u2013HCV (RESIST-HCV) Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated with Direct-Acting Antiviral Agents","volume":"155","author":"Calvaruso","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/14787210.2019.1563755","article-title":"Review: Real life experiences in HCV management in 2018","volume":"17","author":"Andreoni","year":"2019","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_5","unstructured":"WHO (2016). Combating Hepatitis B and C to Reach Elimination by 2030, WHO."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/gut.44.6.874","article-title":"Clinical course and risk factors of hepatitis C virus related liver disease in the general population: Report from the Dionysos study","volume":"44","author":"Bellentania","year":"1999","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/hep.510260431","article-title":"Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy","volume":"26","author":"Guadagnino","year":"1997","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/liv.14796","article-title":"Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements","volume":"41","author":"Kondili","year":"2021","journal-title":"Liver Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0168-8278(00)80167-1","article-title":"Hepatitis C virus infection and alanine transaminase levels in the general population: A survey in a southern Italian town","volume":"33","author":"Maio","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_10","first-page":"11","article-title":"The HCV Sicily Network: A web-based model for the management of HCV chronic liver disease","volume":"20","author":"Cartabellotta","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jmv.10081","article-title":"Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission","volume":"67","author":"Stroffolini","year":"2002","journal-title":"J. Med. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2300712","DOI":"10.2807\/1560-7917.ES.2024.29.29.2300712","article-title":"Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: A retrospective study","volume":"29","author":"Ryan","year":"2024","journal-title":"Eurosurveillance"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e2438657","DOI":"10.1001\/jamanetworkopen.2024.38657","article-title":"Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain","volume":"7","author":"Ryan","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sperle, I., Steffen, G., Leendertz, S.A., Sarma, N., Beermann, S., Thamm, R., Simeonova, Y., Cornberg, M., Wedemeyer, H., and Bremer, V. (2020). Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review. Front. Public Health, 28.","DOI":"10.3389\/fpubh.2020.00424"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12954-023-00774-1","article-title":"HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice","volume":"20","author":"Dichtl","year":"2023","journal-title":"Harm Reduct. J."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rosato, V., Kondili, L.A., Nevola, R., Perillo, P., Mastrocinque, D., Aghemo, A., and Claar, E. (2022). Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions. Viruses, 14.","DOI":"10.3390\/v14051096"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101122","DOI":"10.1016\/j.jhepr.2024.101122","article-title":"Successful hepatitis B and C screening in the health check-up in the German primary care setting","volume":"6","author":"Petroff","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zar\u0119bska-Michaluk, D., Brzd\u0119k, M., Tronina, O., Janocha-Litwin, J., Sitko, M., Piekarska, A., Klapaczy\u0144ski, J., Parfieniuk-Kowerda, A., Sobala-Szczygie\u0142, B., and Tudrujek-Zdunek, M. (2024). Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination. BMC Med., 22.","DOI":"10.1186\/s12916-024-03753-w"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejim.2022.04.024","article-title":"Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination","volume":"101","author":"Isfordink","year":"2022","journal-title":"Eur. J. Intern. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/9\/1252\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:46:39Z","timestamp":1760035599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/9\/1252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":19,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["v17091252"],"URL":"https:\/\/doi.org\/10.3390\/v17091252","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}